You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

Investigational Drug Information for BLD-0409

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for BLD-0409?

BLD-0409 is an investigational drug.

There have been 5 clinical trials for BLD-0409. The most recent clinical trial was a Phase 1 trial, which was initiated on May 31st 2022.

The most common disease conditions in clinical trials are Fatty Liver, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. The leading clinical trial sponsors are Blade Therapeutics and [disabled in preview].

There is one US patent protecting this investigational drug and forty-five international patents.

Recent Clinical Trials for BLD-0409
RESPIRARE Phase 2 Study of Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Blade TherapeuticsPhase 2
Dedicated Drug-Drug Interaction (DDI) Study in Healthy VolunteersBlade TherapeuticsPhase 1
Healthy Volunteer Study Comparing Tablet and Oral Solution FormulationsBlade TherapeuticsPhase 1

See all BLD-0409 clinical trials

Clinical Trial Summary for BLD-0409

Top disease conditions for BLD-0409
Top clinical trial sponsors for BLD-0409

See all BLD-0409 clinical trials

International Patents for BLD-0409

Drugname Country Document Number Estimated Expiration Related US Patent
BLD-0409 Australia AU2016268250 2035-05-27 ⤷  Sign Up
BLD-0409 Australia AU2020239656 2035-05-27 ⤷  Sign Up
BLD-0409 Australia AU2022228098 2035-05-27 ⤷  Sign Up
BLD-0409 Brazil BR112017025420 2035-05-27 ⤷  Sign Up
BLD-0409 Canada CA2986759 2035-05-27 ⤷  Sign Up
BLD-0409 China CN107921048 2035-05-27 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.